Conclusion
Il y a seulement 10 ans, l’arthrose était considérée par les médecins et leur patients comme une fatalité liée à l’âge. Aujourd’hui, on est capable de ralentir la progression de l’usure cartilagineuse grâce aux médicaments chondroprotecteurs, et demain, on pourra sans doute restaurer les lessions anatomiques arthrosiques par le biais de la thérapie cellulaire.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références bibliographiques
Lequesne M (1995) Quantitative measurements of joint space during progression of osteoarthritis: « chondrometry ”. In: Kuettner K, Goldberg V, ed. Osteoarthritis disorders American Academy of Orthop Surgeons. Rosemont, p. 427.
Piperno M.
Chikanza JC, Fernandes L (2000) Novel strategies for the treatment of osteoarthritis. Exp. Opin. Invest. Drugs 9(7): 1499–510.
Jouzeau JY, Gillet P, Netter P (2000) Intérêt des modèles animaux dans le développement préclinique des antiarthrosiques. Rev. Rhum. (éd. fr.) 67: 681–5.
Gilroy DW, Tomlinson A, Greenslade K. et al. (1998) The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of mycobacterium tuberculosis induced monoarticular arthritis in the rat. Inflammation 22: 509–19.
Pelletier JP, Jovanovic D, Lascau-Coman, et al. (2000) Selective inhibition of inducible nitric oxid synthase reduces progression of experimental osteoarthritis in vivo. Possible link with the reduction in chondrocyte apoptosis and caspase-3 level. Arthritis. Rheum. 43: 1290–9.
Manicourt DH, Altman RD, Williams JM (1999) Treatment with calcitonin suppresses the response of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis ans significantly reduces the severity of cartilage lesions. Arthritis. Rheum. 42: 1159–67.
Podworny NV, Kandel RA, Renlund RC, et al. (1999) Partial chondroprotective effect of zoledronate in a rabbit model of inflammatory arthritis. J. Rheumatol. 26: 1972–82.
Yu LP Jr, Smoth GN Jr, Brandt KD, et al. (1992) Reduction of the severity of canine osteoarthritis by prophylactic treatment with oral doxycyclin. Arthritis. Rheum. 35: 1150–9.
Reginster JY, Deroisy R, Rovati LC et al. (2001) Long term effect of glucosamine sulfate on osteoarthritis progression; a randomised, placebo-controlled clinical trial. Lancet 357: 251–6.
Brittberg M, Lindhal A, Nilsson A, et al. (1994) Treatment of deep cartilage defects in the knee with autologous chondrocytes transplantation. New England J. Med. 331: 889–95.
Peterson L, Minas T, Brittberg M, et al. (2000) Two-to 9-year outcome after autologous chondrocyte transplantation of the knee. Clin. Orthop. Rel. Res. 212–34.
Freed LE, Vunjak-Novakovic G, Biron JR, et al. (1994) Biodegradable polymer scaffolds for tissue engineering. Bio/Technology 12: 689–93.
Frenkel SR, Toolan B, Menche D, et al. (1997) Chondrocytes transplantation using a collagen bilayer matrix for cartilage repair. J. Bone Joint Surg. 79(b): 831–6.
Grande DA, Breitbart AS, Mason J, et al. (1999) Cartilage tissue engineering: current limitations and solutions. Clin. Orth. Rel. Res. 376: S176–85.
Jorgensen C, Noel D, Apparailly F, Sany J (2001) Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis. Ann. Rheum. Dis. 60: 305–9.
Chevalier X (2000) La thérapie cellulaire des lésions du cartilage: mise au point et applicabilité à l’arthrose. Rev. Rhum. (éd. fr.) 67: 688–95.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Piperno, M. (2006). Perspectives et avenir dans le traitement médical de l’usure cartilagineuse. In: La gonarthrose. Approche pratique en orthopédie-traumatologie. Springer, Paris. https://doi.org/10.1007/2-287-30285-9_6
Download citation
DOI: https://doi.org/10.1007/2-287-30285-9_6
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-30052-3
Online ISBN: 978-2-287-30285-5